- Home
- RGNX vs MIN Comparison
RGNX vs MIN Comparison
Compare RGNX & MIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- MIN
- Stock Information
- Founded
- RGNX 2008
- MIN 1988
- Country
- RGNX United States
- MIN United States
- Employees
- RGNX N/A
- MIN N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- MIN Trusts Except Educational Religious and Charitable
- Sector
- RGNX Health Care
- MIN Finance
- Exchange
- RGNX Nasdaq
- MIN Nasdaq
- Market Cap
- RGNX 372.1M
- MIN 306.7M
- IPO Year
- RGNX 2015
- MIN N/A
- Fundamental
- Price
- RGNX $7.57
- MIN $2.67
- Analyst Decision
- RGNX Strong Buy
- MIN
- Analyst Count
- RGNX 12
- MIN 0
- Target Price
- RGNX $35.55
- MIN N/A
- AVG Volume (30 Days)
- RGNX 1.8M
- MIN 331.0K
- Earning Date
- RGNX 02-25-2025
- MIN 01-01-0001
- Dividend Yield
- RGNX N/A
- MIN 7.31%
- EPS Growth
- RGNX N/A
- MIN N/A
- EPS
- RGNX N/A
- MIN 0.08
- Revenue
- RGNX $84,327,000.00
- MIN N/A
- Revenue This Year
- RGNX $2.92
- MIN N/A
- Revenue Next Year
- RGNX $256.82
- MIN N/A
- P/E Ratio
- RGNX N/A
- MIN $33.38
- Revenue Growth
- RGNX N/A
- MIN N/A
- 52 Week Low
- RGNX $6.56
- MIN $2.52
- 52 Week High
- RGNX $28.80
- MIN $2.88
- Technical
- Relative Strength Index (RSI)
- RGNX 45.51
- MIN 49.70
- Support Level
- RGNX $6.98
- MIN $2.63
- Resistance Level
- RGNX $7.70
- MIN $2.67
- Average True Range (ATR)
- RGNX 0.54
- MIN 0.03
- MACD
- RGNX 0.04
- MIN 0.00
- Stochastic Oscillator
- RGNX 44.30
- MIN 61.11
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About MIN MFS Intermediate Income Trust
MFS Intermediate Income Trust is a diversified closed-end management investment company. The fund's investment objective is to seek high current income but may also consider capital appreciation. It invests the assets in debt instruments. Its portfolio of investments comprises of different sector investments such as the automotive, chemicals, energy, food and beverages, insurance, and other sectors.